...
首页> 外文期刊>American Journal of Transplantation >Liver Transplantation with Grafts from Controlled Donors after Cardiac Death: A 20-Year Follow-up at a Single Center
【24h】

Liver Transplantation with Grafts from Controlled Donors after Cardiac Death: A 20-Year Follow-up at a Single Center

机译:心脏死亡后从受控供体移植肝移植:在单个中心进行的20年随访

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The first liver transplantation (LTx) in Sweden was performed in 1984, but brain death as a legal death criterion was not accepted until 1988. Between November 1984 and May 1988, we performed 40 consecutive LTxs in 32 patients. Twenty-four grafts were from donors after cardiac death (DCD) and 16 grafts from heart-beating donors (HBD). Significantly, more hepatic artery thrombosis and biliary complications occurred in the DCD group (p < 0.01 and p < 0.05, respectively). Graft and patient survival did not differ between the groups. In the total group, there was a significant difference in graft survival between first-time LTx grafts and grafts used for retransplantation. There was better graft survival in nonmalignant than malignant patients, although this did not reach statistical significance. Multivariate analysis revealed cold ischemia time and post-LTx peak ALT to be independent predictive factors for graft survival in the DCD group. In the 11 livers surviving 20 years or more, follow-up biopsies were performed 18–20 years post-LTx (n = 10) and 6 years post-LTx (n = 1). Signs of chronic rejection were seen in three cases, with no difference between DCD and HBD. Our analysis with a 20-year follow-up suggests that controlled DCD liver grafts might be a feasible option to increase the donor pool.
机译:瑞典于1984年进行了第一次肝移植(LTx),但直到1988年才接受将脑死亡作为法定死亡标准。在1984年11月至1988年5月之间,我们对32例患者进行了40次连续LTx。 24例来自心源性死亡后的捐献者(DCD),16例来自心跳性捐献者(HBD)。值得注意的是,DCD组发生更多的肝动脉血栓形成和胆道并发症(分别为p <0.01和p <0.05)。两组之间的移植物和患者生存率无差异。在整个组中,初次LTx移植物和用于再移植的移植物之间的移植物存活率存在显着差异。非恶性肿瘤的移植物存活率高于恶性肿瘤,尽管这没有统计学意义。多变量分析显示冷缺血时间和LTx峰后ALT是DCD组移植物存活的独立预测因素。在存活20年或更长时间的11例肝脏中,在LTx术后18–20年(n = 10)和LTx术后6年(n = 1)进行了活检。在三例病例中发现了慢性排斥的迹象,DCD和HBD之间无差异。我们对20年随访的分析表明,受控DCD肝移植可能是增加供体库的可行选择。

著录项

  • 来源
    《American Journal of Transplantation》 |2010年第3期|p.602-611|共10页
  • 作者单位

    Division of Transplantation Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden;

    Division of Transplantation Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden;

    Division of Transplantation and Liver Surgery, Department of Surgery, Uppsala University Hospital, Uppsala, Sweden;

    Division of Transplantation Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden;

    Division of Transplantation Surgery, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Complications; deceased donor organs; liver transplantation; survival;

    机译:并发症;供体器官衰弱;肝移植;存活;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号